Minimal İnvaziv Glokom Cerrahisi

Kwon YH, Fingert JH, Kuehn MH, et al. Primary open-angle glaucoma. N Engl J Med. 2009;360(11): 1113-24. doi: 10.1056/NEJMra0804630.

Swaminathan SS, Oh DJ, Kang MH, et al. Aqueous outflow: segmental and distal flow. J Cataract Refract Surg. 2014;40(8): 1263-72. doi: 10.1016/j.jcrs.2014.06.020.

Pereira ICF, van de Wijdeven R, Wyss HM, et al. Conventional glaucoma implants and the new MIGS devices: a comprehensive review of current options and future directions. Eye (Lond). 2021;35(12): 3202-3221. doi: 10.1038/s41433-021-01595-x.

Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153(5): 789-803.e2. doi: 10.1016/j.ajo.2011.10.026.

US Food and Drug Administration. Premarket studies of implantable minimally invasive glaucoma surgical (MIGS) devices: draft guidance for industry and food and drug administration staff. 2015. (04.02.2023 tarihinde https://www.fda.gov/regulatory-information/search-fda-guidance-documents/premarket-studies-implantable-minimally-invasive-glaucoma-surgical-migs-devices adresinden ulaşılmıştır).

Johnson M. 'What controls aqueous humour outflow resistance?'. Exp Eye Res. 2006;82(4): 545-57. doi: 10.1016/j.exer.2005.10.011.

Lee RMH, Bouremel Y, Eames I, et al. Translating Minimally Invasive Glaucoma Surgery Devices. Clin Transl Sci. 2020;13(1): 14-25. doi: 10.1111/cts.12660.

Brandão LM, Grieshaber MC. Update on Minimally Invasive Glaucoma Surgery (MIGS) and New Implants. J Ophthalmol. 2013;2013: 705915. doi: 10.1155/2013/705915.

Chen DZ, Sng CCA. Safety and Efficacy of Microinvasive Glaucoma Surgery. J Ophthalmol. 2017;2017: 3182935. doi: 10.1155/2017/3182935.

Fea AM, Belda JI, Rękas M, et al. Prospective unmasked randomized evaluation of the iStent inject (®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Clin Ophthalmol. 2014;8: 875-82. doi: 10.2147/OPTH.S59932.

Rowson AC, Hogarty DT, Maher D, et al. Minimally Invasive Glaucoma Surgery: Safety of Individual Devices. J Clin Med. 2022;11(22): 6833. doi: 10.3390/jcm11226833.

Samet S, Ong JA, Ahmed IIK. Hydrus microstent implantation for surgical management of glaucoma: a review of design, efficacy and safety. Eye Vis (Lond). 2019;6: 32. doi: 10.1186/s40662-019-0157-y.

Gandolfi SA, Ungaro N, Ghirardini S, et al. Comparison of Surgical Outcomes between Canaloplasty and Schlemm's Canal Scaffold at 24 Months' Follow-Up. J Ophthalmol. 2016;2016: 3410469. doi: 10.1155/2016/3410469.

Lee D, King J, Thomsen S, et al. Comparison Of Surgical Outcomes Between Excisional Goniotomy Using The Kahook Dual Blade And iStent Trabecular Micro-Bypass Stent In Combination With Phacoemulsification. Clin Ophthalmol. 2019;13: 2097-2102. doi: 10.2147/OPTH.S224109.

Samples JR, Ahmed IIK, Ed. Glokomda cerrahi yenilikler, Minimal İnvaziv Glokom Cerrahisi: Ab interno Trabekülektomi. (Aktaş Z, Sarıcaoğlu MS), Çev. Ed. Ankara: HiperTıp; 2018.

Kaplowitz K, Schuman JS, Loewen NA. Techniques and outcomes of minimally invasive trabecular ablation and bypass surgery. Br J Ophthalmol. 2014;98(5): 579-85. doi: 10.1136/bjophthalmol-2013-304256.

Kaplowitz K, Schuman JS, Loewen NA. Techniques and outcomes of minimally invasive trabecular ablation and bypass surgery. Br J Ophthalmol. 2014;98(5): 579-85. doi: 10.1136/bjophthalmol-2013-304256.

Hamze H, Mohite AA, Pandey P, et al. Comparison of 1-year surgical outcomes of combined cataract surgery and gonioscopy-assisted transluminal trabeculotomy (GATT) versus cataract surgery and iStent Inject. Graefes Arch Clin Exp Ophthalmol. 2021;259(10): 3035-3044. doi: 10.1007/s00417-021-05133-z.

Baykara M, Poroy C, Erseven C. Surgical outcomes of combined gonioscopy-assisted transluminal trabeculotomy and cataract surgery. Indian J Ophthalmol. 2019;67(4): 505-508. doi: 10.4103/ijo.IJO_1007_18.

Sarkisian S.R., Mathews B., Ding K., et al. 360° ab-interno trabeculotomy in refractory primary open-angle glaucoma. Clin Ophthalmol. 2019;13: 161–168. doi: 10.2147/OPTH.S189260.

Tracer N, Dickerson JE Jr, Radcliffe NM. Circumferential Viscodilation Ab Interno Combined with Phacoemulsification for Treatment of Open-Angle Glaucoma: 12-Month Outcomes. Clin Ophthalmol. 2020;14: 1357-1364. doi: 10.2147/OPTH.S252965.

Ondrejka S, Körber N. 360° ab-interno Schlemm's canal viscodilation in primary open-angle glaucoma. Clin Ophthalmol. 2019;13: 1235-1246. doi: 10.2147/OPTH.S203917.

Gallardo MJ, Pyfer MF, Vold SD, et al. Canaloplasty and Trabeculotomy Combined with Phacoemulsification for Glaucoma: 12-Month Results of the GEMINI Study. Clin Ophthalmol. 2022;16: 1225-1234. doi: 10.2147/OPTH.S362932.

Vold SD, Williamson BK, Hirsch L, et al. Canaloplasty and Trabeculotomy with the OMNI System in Pseudophakic Patients with Open-Angle Glaucoma: The ROMEO Study. Ophthalmol Glaucoma. 2021;4(2): 173-181. doi: 10.1016/j.ogla.2020.10.001.

Gallardo MJ. 24-Month Efficacy of Viscodilation of Schlemm's Canal and the Distal Outflow System with iTrack Ab-Interno Canaloplasty for the Treatment of Primary Open-Angle Glaucoma. Clin Ophthalmol. 2021;15: 1591-1599. doi: 10.2147/OPTH.S272506.

Davids AM, Pahlitzsch M, Boeker A, et al. Ab interno canaloplasty (ABiC)-12-month results of a new minimally invasive glaucoma surgery (MIGS). Graefes Arch Clin Exp Ophthalmol. 2019;257(9): 1947-1953. doi: 10.1007/s00417-019-04366-3.

Reiss G, Clifford B, Vold S, et al. Safety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study. Am J Ophthalmol. 2019;208: 219-225. doi: 10.1016/j.ajo.2019.07.015.

Gigon A, Shaarawy T. The Suprachoroidal Route in Glaucoma Surgery. J Curr Glaucoma Pract. 2016;10(1):13-20. doi: 10.5005/jp-journals-10008-1197.

Denis P, Hirneiß C, Reddy KP, et al. A First-in-Human Study of the Efficacy and Safety of MINIject in Patients with Medically Uncontrolled Open-Angle Glaucoma (STAR-I). Ophthalmol Glaucoma. 2019;2(5): 290-297. doi: 10.1016/j.ogla.2019.06.001.

Kalina AG, Kalina PH, Brown MM. XEN® Gel Stent in Medically Refractory Open-Angle Glaucoma: Results and Observations After One Year of Use in the United States. Ophthalmol Ther. 2019;8(3): 435-446. doi: 10.1007/s40123-019-0192-8.

Pinchuk L, Riss I, Batlle JF, et al. The use of poly(styrene-block-isobutylene-block-styrene) as a microshunt to treat glaucoma. Regen Biomater. 2016;3(2): 137-42. doi: 10.1093/rb/rbw005.

Sadruddin O, Pinchuk L, Angeles R, et al. Ab externo implantation of the MicroShunt, a poly (styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review. Eye Vis (Lond). 2019;6: 36. doi: 10.1186/s40662-019-0162-1.

Kaplowitz K, Kuei A, Klenofsky B, et al. The use of endoscopic cyclophotocoagulation for moderate to advanced glaucoma. Acta Ophthalmol. 2015;93(5): 395-401. doi: 10.1111/aos.12529.

Chen J, Cohn RA, Lin SC, et al. Endoscopic photocoagulation of the ciliary body for treatment of refractory glaucomas. Am J Ophthalmol. 1997;124(6): 787-96. doi: 10.1016/s0002-9394(14)71696-4.